Category Archives: opinion

Op-ed by Dr. Peter Hotez in the Houston Chronicle: School takes on ancient scourges

Sabin Vaccine President Dr. Peter Hotez wrote an op-ed featured in the Houston Chronicle. Take a look at what Dr. Hotez has to say about Houston being a central hub for NTD elimination:

“Austin, Houston and San Antonio, three of the most populated cities in Texas, have something in common with the world’s great population centers – Cairo, Jerusalem, Petra, Baghdad, Shiraz, Delhi, Kathmandu, Chongqing, Wuhan and Shanghai. All are located on or close to the 30th parallel north. All, to some degree, are home to people in poverty.

Texas Children’s Hospital and Baylor College of Medicine are determined to make a difference in the lives of 100 million people in these cities, and indeed all of the “bottom billion” – the world’s 1.4 billion poorest people – by fighting the diseases that help trap them in poverty, including hookworm, elephantiasis, river blindness, schistosomiasis, leprosy, leishmaniasis and Chagas disease. To that end, we are establishing Baylor College of Medicine’s fourth school, the National School of Tropical Medicine, and moving the Sabin Vaccine Laboratories to the Feigin Center at Texas Children’s Hospital. Together the Houston-based school and vaccine research institute will be the first of their kind in the United States exclusively devoted to combating the neglected tropical infections that have sapped the strength of working men and women and damaged the brains of their children since the earliest recorded time.”

Click here to read the full op-ed.

Africa Looks to the East

By: Charles Ebikeme

In April, China released its first white paper on foreign aid, detailing and outlining its strategy
on aid towards Africa, from financial resources, debt relief, humanitarian aid, and infrastructure
projects. Some saw the white paper as a response to claims of self-serving neocolonialist
tactics by the Chinese, driven by the need for China to sustain its economic development.

While much of the debate on international interest in Africa as an investment destination has
focused on China, India is also showing increased engagement on the African continent. In
May, India offered loans totaling US$5 billion. This came at the top of the second India-Africa
Forum Summit in Addis Ababa, Ethiopia. The extent of India’s involvement in Africa, looking to
match China’s stake-hold, ranges from a new Ethio-Djibouti railway, increased African airline
access to Indian cities, new institutions, as well as lines of credit. India, like China, are also
looking towards political and diplomatic alignment.

China and India, tout a shared common interest with their foreign aid, as both donor and recipients are themselves developing countries. The Indian Prime Minister commenting on a shared former colonial past; “India-Africa partnership is unique and owes its origins to history and our common struggles against colonialism, apartheid, poverty, disease.”

The “post-American world” is seeing the rise of this brand of South-South development cooperation. Indeed, the development landscape is changing as emerging countries become more prominent. In a development aid will be ruled by China, India and Brazil. However, not often enough does the aid debate focus on disease. Aid seems to be still fueled by an interest to grow markets. At a time when some nations in Africa are calling on in fighting tropical diseases.

Continue reading

The Mysterious Disease

By: Charles Ebikeme

Imagine for a moment you don’t live where you live. Let’s say you live in Benin, or Togo, or Côte D’Ivoire, or perhaps Ghana (we can even add Australia to the list). Perhaps one day you notice on your ankle a small, somewhat pointed elevation of the skin. A nodule. What you have is so painless you consider it inconsequential -it will clear up in a few days. You awake one morning with a slight fever. For this particular ailment it would be rare to have a fever, but not unheard of. Where you normally reside “man flu” is the worst-case scenario you can think of. In Contonou, Benin, you can name at least three diseases that start with fever-like symptoms and could end with your death. Your niece died from one of them – before her fifth birthday, and the other caused blindness in your uncle. But this isn’t any of those.  After a few days this nodule is now the size of a boil. In Washington DC, a boil can be excised. In Togo this is worse than a mere boil. Your foot has swollen – so much that it’s hard to stand upright. Even more disconcerting is that this all comes without any pain. What follows can only be described as horrific; a painless necrotizing skin lesion, followed by ulcer and scar formation. Before you know it, your foot is being eaten away from the inside. The lesion grows and grows, oozing fluid and puss. A wide painless ulcer now covers a large area of your lower limb.  With this disease early diagnosis makes all the difference – but it is often rare.  Surgical excision of the infected tissue has long been the first port of call. Today, along with surgery, you are given the antibiotics streptomycin and rifampin for 8 full weeks. That is if it was caught at an early stage. Your doctor did not know what it is until it was too late, as there are four other diseases that cause skin lesions and ulcers.

With treatment lesions heal but with permanent scarring and contractures which limit movement in your limb. You have no outer skin on the right side of your foot.  A skin graft, taking skin from another part of your body, to patch up the infected area is needed. Imagine a small child of less than 15 years of age needing a skin graft. The lesions are sometimes so large that finding enough healthy skin to graft on is impossible. Eventually it will invade your bones, leading to severe disabilities and deformities. Maybe they will have to amputate. Any pain you experience will be due to secondary infections. Secondary infections that might also kill you.  What you have is the second most common bacterial infection we know of – Mycobacterium ulcerans. The bacteria, produces a toxin – mycolactone. Continue reading

The Solutions That Aren’t – Part Two

By: Alanna Shaikh

It makes me wonder. Which of our current successes aren’t going to be seen that way in thirty years?

My dad was an agricultural researcher in the sixties. He was very, very proud of his work on new pesticides. He emigrated from Pakistan to the US specifically so that he could be part of increasing food production and revolutionizing agriculture; Norman Borlaug was a professional colleague. He had no idea that someday people would look at his work and wonder if it was a change for the better.[i]

What are we doing right now that we’ll regret?

Will we give up on bed nets because it is so hard to get people to use them as intended? Or regret manufacturing them in China instead of in the countries where they are used? Conversely, maybe we’ll regret our focus on local production and autonomy and wish we’d just gotten useful products as cheaply as possible and shipped them everywhere.

Maybe we’ll discover that mass drug administration is leading to resistance to common drugs for NTDs, or that it has side effects we didn’t initially know about. On the other hand, maybe we’ll just start putting the necessary drugs right into drinking water to achieve rapid elimination of neglected tropical diseases.

Continue reading